Analyzing Cartesian Therapeutics (NASDAQ:RNAC) and Applied Therapeutics (NASDAQ:APLT)
Cycle Pharmaceuticals Completes Acquisition of Applied Therapeutics
Cycle Pharmaceuticals Announces Extension of Applied Therapeutics Tender Offer
Applied Therapeutics Shares Letter to Stockholders Recommending Tender of Shares Following Offer Expiration Extension
Cycle Pharmaceuticals Announces Extension of Applied Therapeutics Tender Offer
Cycle Pharmaceuticals Announces Extension of Applied Therapeutics Tender Offer
Applied Therapeutics Inc. (NASDAQ:APLT) Short Interest Update
Here's Why Applied Therapeutics (APLT) Is a Great 'Buy the Bottom' Stock Now
APLT Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Applied Therapeutics, Inc. is Fair to Shareholders
Cycle Pharmaceuticals to Acquire Applied Therapeutics
Applied Therapeutics (APLT) Upgraded to Buy: Here's Why
Applied Therapeutics Announces Corporate Updates
Applied Therapeutics Tanks As FDA Path For Lead Rare-Disease Drug Turns Uncertain
Applied Therapeutics Reports Third Quarter 2025 Financial Results
Halper Sadeh LLC Encourages Applied Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their Rights
Applied Therapeutics Provides Update Following Meeting with FDA
Applied Therapeutics Reports Second Quarter 2025 Financial Results
Applied Therapeutics Announces Key Leadership Appointments
Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting
Applied Therapeutics Reports First Quarter 2025 Financial Results
Applied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting
NET Power Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. June 17, 2025 Deadline to file Lead Plaintiff Motion
Applied Therapeutics Files Form 12b-25 with the Securities and Exchange Commission
Applied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics, Inc. Lawsuit - APLT
Shareholders of Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights – APLT
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Applied Therapeutics, Inc.(APLT) Shareholders
Investors in Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
APLT DEADLINE NOTICE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action - APLT
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Applied Therapeutics, Inc.(APLT) Shareholders
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Applied Therapeutics, Inc.(APLT) Shareholders
FINAL REMINDER APLT DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts Applied Therapeutics, Inc. Investors to Participate in the Class Action Lawsuit
Class Action Filed Against Applied Therapeutics, Inc. (APLT) - February 18, 2025 Deadline to Join - Contact Levi & Korsinsky
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Applied Therapeutics, Inc. (APLT) Shareholders
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) should contact Levi & Korsinsky about pending Class Action - APLT
APLT COURT NOTIFICATION: Suffer Losses on Applied Therapeutics? Contact BFA Law by Tomorrow's Class Action Deadline
Shareholders that lost money on Applied Therapeutics, Inc. (APLT) should contact Levi & Korsinsky about pending Class Action - APLT
APLT DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action - APLT
Applied Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Applied Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - APLT
DEADLINE APPROACHING: Applied Therapeutics, Inc. Is Being Sued For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm
February 18, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against - APLT
APLT LAWSUIT ALERT: Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
FINAL APLT DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Applied Therapeutics, Inc. Investors to Join the Class Action Lawsuit
Class Action Filed Against Applied Therapeutics, Inc. (APLT) - February 18, 2025 Deadline to Join - Contact Levi & Korsinsky
INVESTOR DEADLINE TOMORROW: Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - APLT
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) should contact Levi & Korsinsky about pending Class Action - APLT
APLT Deadline in 2 Days: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Filing Deadline in Class Action Lawsuit
Investors who Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky About Pending Class Action - APLT
Levi & Korsinsky Notifies Shareholders of Applied Therapeutics, Inc. (APLT) of a Class Action Lawsuit and an Upcoming Deadline